跳至主要内容
临床试验/RBR-37qx63d
RBR-37qx63d尚未招募1 期

Assessment of the tolerability and safety of Administration of different doses of Psilocybin in Healthy adults.

Biocase Brasil0 个研究点开始时间: 2024年2月17日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
21Y 至 65Y(—)

入选标准

  • Adults without comorbidities aged between 21 and 65 years from both gender

排除标准

  • Participants who meet any of the following exclusion criteria are not eligible for the study including use of medications that may interfere with the study drug, history of heart, liver, kidney disease, history of cancer or organ transplant, insulin dependent diabetes or uncontrolled diabetes, gastrointestinal disease that may interfere with the absorption of the substance orally, current or past history of psychiatric disorders as schizophrenia, psychotic disorder, bipolar disorder, personality disorder, first degree family history of psychiatric disorders, seizures or fainting, creatinine elevation, nicotine dependence that would prevent an individual from being nicotine-free for 7 to 10 hours during the dosing period, women who are pregnant or intending to become pregnant during the study or who are currently breastfeeding, chemical dependency or abuse of alcohol or illicit drugs in the last 12 months, platelets disorders, clinically significant anemia, liver injury

研究者

发起方
Biocase Brasil

相似试验